Join
Live feed
·
INSIDERFilingvia Quantisnow
MBX Biosciences Inc. logo

President & CEO Hawryluk P. Kent was granted 35,250 shares, increasing direct ownership by 5% to 699,506 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MBX· MBX Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MBX (MBX Biosciences Inc.) and more on Quantisnow.